| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $335.7M | +6.4% |
| Cost of Revenue | $181.0M | -4.2% |
| Gross Profit | $154.7M | +22.1% |
| R&D Expense | $21.6M | +3.7% |
| SG&A Expense | $72.6M | -3.6% |
| Operating Income | -$42.5M | +61.1% |
| Pre-tax Income | -$36.5M | +64.4% |
| Income Tax | -$588K | -660.0% |
| Net Income | -$35.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $113.8M | -9.3% |
| Accounts Receivable | $29.6M | -30.0% |
| Inventory | $24.8M | +13.6% |
| Current Assets | $185.5M | -10.4% |
| Total Assets | $296.2M | -9.2% |
| Current Liabilities | $76.7M | +5.8% |
| Total Liabilities | $122.3M | +0.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.9M | +282.9% |
| Capital Expenditures | $3.4M | -35.6% |
| Investing Cash Flow | -$14.0M | +76.4% |
| Financing Cash Flow | $265K | -72.4% |
| Free Cash Flow | $2.6M | +130.2% |
| +65.0% |
| EPS (Basic) | -$1.52 | +65.6% |
| EPS (Diluted) | -$1.52 | +65.6% |
| Stockholders' Equity |
| $173.9M |
| -15.1% |